In a groundbreaking move, Abu Dhabi’s Department of Health Abu Dhabi has granted early access to WINREVAIR, a cutting-edge medication for Pulmonary Arterial Hypertension (PAH). This initiative marks a pivotal moment, as Abu Dhabi becomes the first in the region…
The Department of Health – Abu Dhabi (DoH), in partnership with the Authority of Social Contribution – Ma’an, has allocated over AED 19 million in grants through the Healthcare Research and Innovation Fund. These grants aim to propel advancements in…
UAE Abu Dhabi based Mubadala Investment Company, the Abu Dhabi-based sovereign investor, has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH). This acquisition aims to bolster Mubadala’s…
BioSapien, a pioneering drug delivery platform focused on localized cancer treatment, has announced the successful closure of a $5.5 million (AED 20.2 million) pre-Series A funding round. The round was led by Global Ventures, with participation from Dara Holdings. Fueling…
Abu Dhabi has licensed the Institute for Healthier Living Abu Dhabi (IHLAD) as the world’s first specialized Healthy Longevity Medicine Centre. Developed under the Department of Health Abu Dhabi (DoH) regulatory framework, this groundbreaking initiative aims to revolutionize healthcare by…
